Researchers at the Children’s Cancer Institute have discovered a combination of therapies that appear highly effective at combatting neuroblastoma and other forms of aggressive childhood cancer.
An international research team has developed a new algorithm based on blood and cerebrospinal fluid biomarker measurements for the diagnostics of dementia.